Search research articles
Contact Us
Filters
Showing results (861-870 of 992) with videos related to
Page
of 100
Sort By:
Haematologica
|
March 9, 2010
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
Teresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
Nature Communications
|
June 13, 2022
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Emanuele Andreano, Ida Paciello, Silvia Marchese, et al.
The Journal of Pathology
|
November 14, 2008
A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands
E Chanudet, H Ye, J Ferry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study
Emanuele Zucca, Annarita Conconi, Daniele Laszlo, et al.
Leukemia & Lymphoma
|
February 17, 2018
Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy
Roberta Burnelli, Simona Rinieri, Roberto Rondelli, et al.
Haematologica
|
October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Pathologica
|
September 8, 2012
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue
H Rizvi, J C Paterson, S Tedoldi, et al.
Blood Advances
|
February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
Saveria Mazzara, Laura Travaini, Francesca Botta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
Page
of 100
Search research articles
Search
Showing results (861-870 of 992) with videos related to
Sort By:
Page
of 100
Haematologica
|
March 9, 2010
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
Teresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
Nature Communications
|
June 13, 2022
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Emanuele Andreano, Ida Paciello, Silvia Marchese, et al.
The Journal of Pathology
|
November 14, 2008
A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands
E Chanudet, H Ye, J Ferry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study
Emanuele Zucca, Annarita Conconi, Daniele Laszlo, et al.
Leukemia & Lymphoma
|
February 17, 2018
Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy
Roberta Burnelli, Simona Rinieri, Roberto Rondelli, et al.
Haematologica
|
October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Pathologica
|
September 8, 2012
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue
H Rizvi, J C Paterson, S Tedoldi, et al.
Blood Advances
|
February 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
Saveria Mazzara, Laura Travaini, Francesca Botta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
Page
of 100